DPhG annual meeting 2026 – Regensburg, Germany, 2026. Maurice L. Nelles*, Timo Muffel*, Dmitri Segal, Lisa Kainacher, Thomas M. Geiger, Radosław P. Nowak, Georg E. Winter, Christian Steinebach: Harnessing Chemical Inducers of Proximity for Transcriptional Reprogramming and Chromatin Remodeling. Sievers, J.*, Pioppini, C., Krupp, A., Krönke, J., Steinebach, C.: Direct Recruitment of Target Proteins to the Proteasome via RPN13
GDCh Colloquium – Greifswald, Germany, 2026. C. Steinebach*: Novel Induced Proximity Modalities in Drug Discovery
CRS 2026 Annual Meeting & Exposition – Lisbon, Portugal, 2026. A. Stakemeier, L. Mild, C. Steinebach, K. G. Wagner: Formulation-Driven Solubility Enhancement of PROTAC ARCC-4 through Acid-Incorporated Eudragit® EPO ASDs.
ACSMEDI-EFMC MedChem Frontiers 2026 – Dublin, Ireland, 2026. A. Maksutova, C. Steinebach, M. Gütschow: Cereblon ligands design, synthesis and implementation in PROTAC technology.
CCC-MV Conference on Translational Cancer Research – Greifswald, Germany, 2026. J. Sievers*, Y. L. D. Ng, F. Lu, J. Krönke, I. Sosič, C. Steinebach: MedChem Approaches Towards BCL-2-Selective Degraders. M. Nelles*, T. Muffel, T. Geiger, N. Nowak, C. Steinebach: Property-Driven Optimization of Transcriptional/Epigenetic CIPs.
EHA 2026 Congress – Stockholm, Sweden, 2026. M. R. Zuleeg, K. Peter, A. Murgai, V. Sapozhnikova, P. Lemnitzer, C. Pioppini, M. Sterev, N. Heisterkamp, T. Krautloher, J. Barinka, S. Haas, L. Bullinger, U. Keller, C. Steinebach, P. Mertins, S. Bohl, J. Krönke: USP7 is a therapeutic target in TP53-mutated acute myeloid leukemia
6th TPD & Induced Proximity Summit Europe – London, United Kingdom, 2026. M. Nelles*, T. Muffel, T. Geiger, N. Nowak, C. Steinebach: Property-Driven Optimization of Transcriptional/Epigenetic CIPs.
